endpoints.news
is our new home on June 1. endpts.com will still work, but the front door is now
https://endpoints.news
Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Analysts start to sort out which biopharma companies’ R&D plans are most threatened by a pandemic
6 years ago
R&D
Coronavirus
In search of a Kuur: Cell Medica rebrands and regroups, taking a new name, a new CEO and new money
6 years ago
R&D
FDA drafts guidance on alternate electronic formats, announces support for new data standards
6 years ago
FDA+
The global top 50 biopharma companies — Endpoints News style
6 years ago
R&D
Silverback Therapeutics gets $78M boost to 'reconceptualize' antibody-drug conjugates
6 years ago
Financing
Startups
After hitting big in multiple myeloma, J&J, Genmab now have a new 'breakthrough' in NSCLC to boast about
6 years ago
FDA+
Intarcia's speed bump at the FDA turns into a roadblock, as regulators once again turn thumbs down on diabetes ...
6 years ago
R&D
Pharma
Biogen outbreak now tied to 70 cases of coronavirus as state total more than doubles in 1 day
6 years ago
Coronavirus
Coronavirus update: Eli Lilly staffer tests positive, FDA postpones inspections and AACR is canceled as outbreak ...
6 years ago
Coronavirus
Syneos up for sale — report; Takeda's Ninlaro fails PhIII in multiple myeloma; EMA braces for drug shortage
6 years ago
News Briefing
To arm the immune system for sustained attack against HIV, NIH scientists take to viral vectors
6 years ago
R&D
Cell/Gene Tx
J&J's favorite CAR-T developer, currently owned by a Chinese CRO, is laying the groundwork for US IPO
6 years ago
Financing
Cell/Gene Tx
Which top-level Biogen exec has tested positive for coronavirus? WSJ narrows the lottery to 4, including the CEO
6 years ago
Coronavirus
Israel’s Arkin Holdings launches second biotech fund, worth $140 million
6 years ago
Financing
Gates Foundation, Mastercard, Wellcome launch coronavirus treatment accelerator as outbreak deepens
6 years ago
Coronavirus
Versant woos MorphoSys' ex-CSO to its booming discovery engine, with big plans for new startups
6 years ago
People
Financing
Bristol Myers backs a European VC's record-setting biotech venture fund, which tops out at $600M
6 years ago
R&D
Pharma
Another myostatin program combusts, but Acceleron has plenty in the pipeline
6 years ago
R&D
Nine new coronavirus cases are tied to the Biogen outbreak — as infections spread to 'close contacts'
6 years ago
People
Pharma
Unum racks up yet another FDA hold as it twists its way through a restructuring, looking for a fresh start with a ...
6 years ago
R&D
Inovio files for $50M offering amid Covid-19 vaccine hunt; Zydus Cadila signs on with XOMA on IL-2 deal
6 years ago
News Briefing
Chinese biotech bags $50M+ for I/O, autoimmune work, starting with ALK5 inhibitor
6 years ago
Financing
China
Bristol Myers flunks frontline multiple myeloma trial, turning attention to cell therapy
6 years ago
R&D
Cell/Gene Tx
ACC scraps its flagship event in Chicago as Covid-19 fears spread faster than the virus
6 years ago
Coronavirus
First page
Previous page
854
855
856
857
858
859
860
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit